Upstream Biotechnology Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Seed

  • Investors
  • 12

Upstream Biotechnology General Information

Description

Developer of disease-resistant crops intended to eliminate pesticide use. The company uses ribonucleic acid-based plant trait development, gene expression control, stress-responsive plant technologies, crop trait validation, and research collaboration capabilities to improve crop resilience against environmental stress, enabling agricultural biotechnology organizations and plant breeders to develop resilient crops, improve agricultural productivity, and support sustainable farming practices.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 701 West Main Street
  • Suite 200
  • Durham, NC 27701
  • United States
+1 (252)
Primary Industry
Cultivation
Other Industries
Other Agriculture
Vertical(s)
Corporate Office
  • 701 West Main Street
  • Suite 200
  • Durham, NC 27701
  • United States
+1 (252)

Upstream Biotechnology Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Upstream Biotechnology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Seed Round 28-Jul-2026 Completed Generating Revenue
8. Accelerator/Incubator 01-Jan-2026 Completed Generating Revenue
7. Seed Round 03-Sep-2025 Completed Generating Revenue
6. Accelerator/Incubator 17-Jan-2024 Completed Generating Revenue
5. Accelerator/Incubator 01-Jan-2024 Completed Generating Revenue
4. Debt - General 01-Oct-2023 Completed Generating Revenue
3. Grant 01-Jan-2022 Completed Generating Revenue
2. Grant 01-Feb-2019 $225K Completed Startup
1. Accelerator/Incubator 21-Nov-2017 Completed Startup
To view Upstream Biotechnology’s complete valuation and funding history, request access »

Upstream Biotechnology Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed
To view Upstream Biotechnology’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Upstream Biotechnology Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Upstream Biotechnology Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Corteva Corporation Minority
LeVert Ventures Venture Capital Minority
Redstick Ventures Venture Capital Minority
SilverBlue Venture Capital Minority
Skull Diamond and Heart Capital Venture Capital Minority
You’re viewing 5 of 12 investors. Get the full list »

Upstream Biotechnology FAQs

  • When was Upstream Biotechnology founded?

    Upstream Biotechnology was founded in 2017.

  • Where is Upstream Biotechnology headquartered?

    Upstream Biotechnology is headquartered in Durham, NC.

  • What is the size of Upstream Biotechnology?

    Upstream Biotechnology has 9 total employees.

  • What industry is Upstream Biotechnology in?

    Upstream Biotechnology’s primary industry is Cultivation.

  • Is Upstream Biotechnology a private or public company?

    Upstream Biotechnology is a Private company.

  • What is Upstream Biotechnology’s current revenue?

    The current revenue for Upstream Biotechnology is .

  • How much funding has Upstream Biotechnology raised over time?

    Upstream Biotechnology has raised $825K.

  • Who are Upstream Biotechnology’s investors?

    Corteva, LeVert Ventures, Redstick Ventures, SilverBlue, and Skull Diamond and Heart Capital are 5 of 12 investors who have invested in Upstream Biotechnology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process